3.505USD-1.68%Mkt Cap: 757.61M USDP/E: —Last update: 2026-06-01
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment. The company utilizes conditional activation platfo…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap757.61M USD
Enterprise Value439.88M USD
Revenue (TTM)35.54M USD
Gross Profit35.54M USD
Net Income (TTM)-17.37M USD
Revenue/Share0.2210 USD
Last Price3.505 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees69
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.01
PEG—
EV/EBITDA-7.26
EV/Revenue12.38
P/S22.05
P/B2.45
EPS (TTM)-0.52
EPS (Forward)-0.51
52W Range
1.72028% of range8.210
52W High8.210 USD
52W Low1.720 USD
Profitability
Gross Margin100.00%
Oper. Margin-191.77%
EBITDA Margin-170.54%
Profit Margin-22.79%
ROE-17.54%
ROA-11.46%
Growth
Revenue Growth-79.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-75.59M USD
CapEx (TTM)220.00K USD
FCF Margin-117.91%
FCF Yield-5.53%
Net Debt-343.85M USD
Net Debt/EBITDA5.67
Balance Sheet
Debt/Equity0.04
Current Ratio10.38
Quick Ratio10.21
Book Value/Sh1.470 USD
Cash/Share1.593 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)12.44 USD
Target Range6.000 USD – 16.00 USD
# Analysts9
Ownership
Shares Out.217.70M
Float186.26M
Insiders0.59%
Institutions96.32%
Short Interest
Short Ratio9.3d
Short % Float16.23%
Short % Out.14.30%
Shares Short31.13M
Short (prev mo.)27.52M
Technical
SMA 504.227 (-17.1%)
SMA 2003.974 (-11.8%)
Beta2.17
S&P 52W Chg27.94%
Avg Vol (30d)3.07M
Avg Vol (10d)3.19M
Technical Indicators
RSI (14)35.8
MACD-0.1780
MACD Signal-0.1947
MACD Hist.+0.0167
BB Upper4.237 USD
BB Middle3.834 USD
BB Lower3.431 USD
BB Width21.02%
ATR (14)0.2247 USD
Vol Ratio (20d)0.38x